window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Cancer Research

  • Biotech,Drug Development,Oncology,Research & Development,Technology and platforms

    SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research

    SPT Labtech and BellBrook Labs have introduced a miniaturised high-throughput [...]

    February 11, 2026
  • Clinical Development,Oncology,Partnerships & Funding,Regulatory Affairs,Research & Development,Technology and platforms

    Start and Advarra unite to accelerate early-phase oncology trials with integrated technology

    The START Center for Cancer Research has formed a strategic [...]

    July 25, 2025
  • Artificial Intelligence,Drug Development,Oncology,Partnerships & Funding,Technology and platforms

    Scientist.com expands AI-powered Tumor Model Finder with XenoSTART cancer models

    Scientist.com has expanded its AI-powered Tumor Model Finder through a [...]

    July 24, 2025
  • Biologics & Biosimilars,Drug Development,Oncology,Research & Development

    Why immunotherapy sometimes fails: Study reveals unintended effects of antibody design

    A new study from researchers in Japan has uncovered a [...]

    July 24, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Drug Development

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 30, 2025
  • Clinical Trials,Drug Development

    START and OneOncology expand access to early phase cancer trials in US communities

    A new partnership will bring early phase clinical trials closer [...]

    May 28, 2025
  • Cell & Gene Therapy

    Cycuria Therapeutics launches with advisory board and major grant funding

    April 28, 2025
  • Cell & Gene Therapy

    BioSkryb Genomics and Tecan launch single-cell multiomics workflow for faster sequencing

    April 28, 2025
  • Drug Delivery & Formulation

    Carthera hits major recruitment milestone in glioblastoma trial using BBB-opening ultrasound device

    Carthera has enrolled the first 100 participants in its Sonobird [...]

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome
    Categories: Central Nervous System, Clinical Development, Drug Delivery & Formulation, Drug Development, Neurosciences, Patient Centricity
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top